Drugs / 68Ga labeled HER2 Affibody
68Ga labeled HER2 Affibody
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05411432 | Jun 2022 → Jun 2023 | carcinoma | Xijing Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga labeled HER2 Affibody | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05411432 ↗ |
| Modality | Diagnostic / imaging agent | “positron emission tomography (PET) imaging probe” NCT05411432 ↗ |